Nalaganje...
Targeting cyclooxygenase enzyme for the adjuvant COVID‐19 therapy
Despite vigorous efforts, the COVID‐19 pandemic continues to take a toll on the global health. The contemporary therapeutic regime focused on the viral spike proteins, viral 3CL protease enzyme, immunomodulation, inhibition of viral replication, and providing a symptomatic relief encouraged the repu...
Shranjeno v:
| izdano v: | Drug Dev Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Inc.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8013002/ https://ncbi.nlm.nih.gov/pubmed/33496060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21794 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|